UDC
547.792'854.4-145.55:615.276.015.11
A. S. Gotsulya, A. V. Samko, O. I. Panasenko
Anti-inflammatory
activity of
2-(5-((theophylline-7'-yl)methyl)-4-R-4H-1,2,4-triazole-3-ylthio)acetic acid salts
Zaporozhye State Medical
University
Abstract. Conducted the research of the inflammatory activity
of the salts of 2-(5-((theophylline-7'-yl)methyl)-4-R-4Н-1,2,4-triazole-3-ylthio)acetate acid on the model of acute
inflammation "formalin-induced edema of the extremities" of rats.
Inflammatory reaction was modeled using 2,0% aqueous formalin solution. As a
reference-preparation used sodium diclofenac. The research results have been
processed by modern statistical methods of analysis. As the research results
shows, the most active are 2-(5-((theophylline-7'-yl)methyl)-4-R-4Н-1,2,4-triazole-3-ylthio)аcetate acid
and it’s diethyletanolammonium salt. Among the studied substances should also
be noted a piperidine 2-(5-((theophylline-7'-yl)methyl)-4-phenyl-4Н-1,2,4-triazole-3-ylthio)acetate, which
shows a high anti-inflammatory activity.
Key words: triazoles, theophylline, anti-inflammatory agents
Entry. The most common and frequently used in
a number of diseases group of drugs NSAIDs are used to relieve inflammation or
as an analgesic. The most active anti-inflammatory effect possessed by those
NSAIDs non-selectively inhibit the cyclooxygenase-1 (COX-1) and
cyclooxygenase-2 (COX-2), disrupting the synthesis of prostaglandins and
tromboksanov and, unfortunately, have a number of unwanted effects associated
with ulcerogenic action of drugs. It is known that among guut NSAIDs selective
COX-2 anti-inflammatory effect is much lower, but almost no side effects on the
gastrointestinal mucosa, but leaves open the question of the use of selective
COX-2 inhibitors in patients with risk of cardiovascular and cerebrovascular
pathology.
As well as anti-inflammatory drugs
myristoleate GCS, mechanism of action of which is based on the suppression of
the transcription of the genes encoding the synthesis of proinflammatory
proteins. The severity of the complications of GKS based on the level of their
application and duration of use. Most often with long-term use of
corticosteroids objnum effect is the development of candidiasis of the oral
cavity, and one of the main complications of GCS is the occurrence of
osteoporosis.
Thus, it is important to search for
highly effective medicines, which could exhibit pronounced anti-inflammatory
effect, but have a smaller segment of side effects. [1, 2, 3].
The aim of this work is to evaluate
anti-inflammatory activity of salts of 2-(5-((theophylline-7'-yl)methyl)-4-R-4H-1,2,4-triazole-3-ylthio)acetic acid
model of acute inflammation "formalin-induced edema of the limbs" of
laboratory rats.
Materials and methods research. For the study was selected of 14
salts of 2-(5-((theophylline-7'-yl)-methyl)-4-phenyl-4H-1,2,4-triazole-3-ylthio)-acetic acid
(tab.1), was synthesized at the Department of Toxicological and inorganic
chemistry of Zaporozhye State Medical University. All experiments were
conducted on intact white nonlinear rats of both sexes weighing from 190 to 260
grams for 7 animals in each group.
To achieve the purpose, an aqueous
solution or suspension of the studied salts, stable tween-80 for
water-insoluble compounds (at a dose of 1/10 of LD50 per 1 ml of
solution/suspension or 100 g. animals), was administered per os 30 min before the introduction of flogogen. Modeling the
inflammatory response conducted by introducing as flogogen of 2.0% aqueous
formalin solution [5]. Formalin was injected in a volume of 0.1 ml sub plantar
in one of the hind limbs. Evaluation of anti-inflammatory activity was
performed after 2 and 4 hours after administration of formalin by measuring
volume of limbs volumetrically method. The limb volume expressed in cm3.
As a reference drug used was diclofenac sodium (2,5% solution, ampoules of 3
ml, "Darnitsa", Ukraine), which was administered at a dose of 8 mg/kg
[5].
The research results are processed by
statistical methods of the analysis using, in particular, the standard software
package of Microsoft Office 2016 (Microsoft Excel) and "STATISTICA®
for Windows 6.0". Calculated average arithmetic (M) and standard error
(±m). The reliability of intergroup differences according to the experimental
data was established using a student's t-test. Used 3 the level of statistical
significance of research results, p<0.05; p<0.01; p<0,001 [4, 6, 8]
Table 1
Salts of
2-(5-((theophylline-7'-yl)methyl)-4-R-4H-1,2,4-triazole-3-ylthio)-acetic
acid
|
№ |
R |
X+ |
№ |
R |
X+ |
|
1 |
СН3 |
Na+ |
8 |
С6Н5 |
½ Ca2+ |
|
2 |
СН3 |
|
9 |
С6Н5 |
½ Zn2+ |
|
3 |
С2Н5 |
|
11 |
С6Н5 |
|
|
4 |
С2Н5 |
|
10 |
С6Н5 |
|
|
5 |
С2Н5 |
|
12 |
С6Н5 |
|
|
6 |
С2Н5 |
|
13 |
С6Н5 |
|
|
7 |
С6Н5 |
Н+ |
14 |
С6Н5 |
|
Table 2
The
anti-inflammatory activity of the salts of
2-(5-((theophylline-7'-yl)methyl)-4-R-4Н-1,2,4-triazole-3-ylthio)acetate
acid
|
№ |
Compound/ group |
Dose of
compound mg/kg |
The volume of paws of rats after 2 h, cm3 |
Anti-inflammatory
activity, % |
·
The
statistical significance of the results |
The
volume of paws of rats after 4 h, cm3 |
Anti-inflammatory
activity, % |
The statistical significance of the results |
||
|
in relation to the control |
in relation to
diclofenac |
in relation to the control |
in relation to
diclofenac |
|||||||
|
1 |
Control of phus.
sol. |
- |
0,46±0,027 |
0 |
- |
р = 0,006 |
1,33±0,051 |
0 |
- |
р=0,00027 |
|
2 |
Ddiclofenac |
8 |
0,34±0,015 |
25,36 |
р = 0,006 |
- |
0,81±0,058 |
38,78 |
р=0,00027 |
- |
|
3 |
2 |
45 |
0,19±0,019 |
59,06 |
р = 7,39*10-5 |
р = 0,000357 |
1,29±0,079 |
7,52 |
р=0,32 |
р=0,0038 |
|
4 |
6 |
46 |
0,19±0,023 |
59,38 |
р=1,2*10-4 |
р = 0,00081 |
1,09±0,076 |
18,15 |
р=0,032 |
р=0,023 |
|
5 |
10 |
55 |
0,47±0,043 |
-3,12 |
р = 0,78 |
р = 0,02206 |
1,11±0,062 |
16,76 |
р=0,027 |
р=0,0104 |
|
6 |
14 |
53 |
0,38±0,028 |
17,19 |
р=0,08 |
р = 0,264 |
1,20±0,082 |
9,99 |
р=0,0066 |
р=0,212 |
|
7 |
Control |
- |
0,39±0,039 |
0 |
- |
- |
1,35±0,063 |
0 |
- |
- |
|
8 |
1 |
121 |
0,72±0,044 |
-83,33 |
р=0,0008 |
р = 7,81*10-5 |
1,26±0,099 |
6,36 |
р=0,4868 |
р=0,0057 |
|
9 |
3 |
45 |
0,63±0,027 |
-61,84 |
р=0,0013 |
р = 2,9*10-5 |
1,21±0,067 |
10,59 |
р=0,1621 |
р=0,0030 |
|
10 |
7 |
105 |
0,19±0,036 |
51,99 |
р=0,006 |
р = 0,0058 |
0,80±0,175 |
40,57 |
р=0,0214 |
р=0,946 |
|
11 |
13 |
50 |
0,21±0,027 |
46,41 |
р=0,00627 |
р = 0,00389 |
0,92±0,112 |
32,10 |
р=0,0116 |
р=0,456 |
|
12 |
Control |
- |
0,37±0,028 |
0 |
- |
- |
1,38±0,091 |
0 |
- |
- |
|
13 |
5 |
49 |
0,57±0,027 |
-53,26 |
р=0,0013 |
р = 0,000126 |
1,20±0,083 |
13,43 |
р=0,1756 |
р=0,0068 |
|
14 |
11 |
50 |
0,20±0,039 |
46,74 |
р=0,00819 |
р = 0,011302 |
1,13±0,063 |
18,08 |
р=0,0585 |
р=0,0073 |
|
15 |
Control |
- |
0,40±0,18 |
0 |
- |
- |
1,14±0,091 |
0 |
- |
- |
|
16 |
4 |
55 |
0,35±0,030 |
10,47 |
р=0,27 |
р = 0,67822 |
1,31±0,097 |
-15,16 |
р=0,2364 |
р=0,00312 |
|
17 |
8 |
115 |
0,16±0,009 |
60,65 |
р=7,35*10-6 |
р = 1,41*10-5 |
0,80±0,134 |
29,70 |
р=0,0749 |
р=0,932103 |
|
18 |
9 |
157 |
0,50±0,033 |
-27,44 |
р=0,23 |
р = 0,00235 |
1,37±0,079 |
-20,05 |
р=0,1018 |
р=0,000777 |
|
19 |
12 |
53 |
0,13±0,016 |
67,51 |
р=1,12*10-5 |
р = 2,5*10-5 |
0,62±0,080 |
45,74 |
р=0,00362 |
р=0,08815 |
Results and their discussion. The results of studies given in table
1 found that 2-(5-((theophylline-7'-yl)methyl)-4-R-4H-1,2,4-triazole-3-ylthio)acetic acid and its salt
diethylethanolamine exceed power of the anti-inflammatory action of the
reference drug as a 2 (26,63 % - 42,15 %, respectively, P ≤ 0,01) and 4
hours (by 1,79 % and of 6,96 %, respectively, P ≤ 0,05). Also it should
also be noted piperidine 2-(5-((theophylline-7'-yl)methyl)-4-phenyl-4H-1,2,4-triazole-3-ylthio)-acetate,
which showed high anti-inflammatory effect, the strength of which is close to
the action of diclofenac sodium (6,68% less active P ≤ 0,05). 4 Hours
connection 2, 5, 6, 8, 10, 11, 13 and 14 also showed a slight anti-inflammatory
effect (in the range of 6,36 % - 32,10 %). 2 hours after the introduction of flogogen
reduced the level of edema 7 connections more efficiently than the standard comparison.
It was found that the presence of the cation diethylethanolamine in the
molecule 2-(5-((theophylline-7'-yl)methyl)-4-R-4H-1,2,4-triazole-3-ylthio)acetate contributes to the identification
of the most strong anti-inflammatory action. The lack of cation
diethylethanolamine in the molecule 2-(5-((theophylline-7'-yl)methyl)-4-R-4H-1,2,4-triazole-3-ylthio)acetate acid
was slightly reduced performance. Introduction cation morpholine to the synthon
reduces the anti-inflammatory effect obtained salt is less effective than the
reference drug.
Conclusions
1. According to the results of the
pharmacological screening of salts of 2-(5-((theophylline-7'-yl)methyl)-4-R-4H-1,2,4-triazole-3-ylthio)acetic acid
revealed a number of compounds with anti-inflammatory activity, which approach
or exceed the activity of the reference drug.
2. Diethylethanolamine
2-(5-((theophylline-7'-yl)methyl)-4-R-4H-1,2,4-triazole-3-ylthio)acetate
was the most active compound: when the application of reduced manifestations
formalin edema within 4 hours by 45,74 %, which is 6,96% more active diclofenac
(38,78 %, p = 0,00027).
Literature
1.
Иманаева А. Я. Изучение
противовоспалительной активности липоевой кислоты на модели адъювант-индуцированного
артрита крыс / А. Я. Иманаева, Л. Н. Залялютдинова, Д. Э. Цыплаков // Biological sciences. Fundamental research. – 2013. – №6. – P. 596.
2. Димефосфон проявляет противовоспалительную и антиоксидантную
активность на модели хронического аутоиммунного воспаления / И. Х. Валеева, Л.
Е. Заганшина, В. Н. Хазиахметова, А. Ф. Титаренко // Экспериментальная и
клиническая фармакология. – 2011, №3. – С.13 – 16.
3. Калитник А. А. Противовоспалительная активность хитозана и
его низкомолекулярного производного / А. А. Калитник, П. А. Марков, А. В. Володько // Медицинский академический журнал. –
2012. – Т. 12, №3. – С. 60.
4. Лапач С. Н. Статистические методы в медико-биологических
исследованиях с использованием Excel / С. Н. Лапач, А. В. Чубенко, П. Н. Бабич.
– [2 изд.], перераб. и доп. – К. : Морион, 2001. – 408
с.
5. Методичні вказівки по доклінічному вивченню лікарських
засобів: Під ред. А. В. Стефанова. – К., 2001. – 567 с.
6. Реброва О. Ю. Статистический анализ медицинских
данных. Применение пакета прикладних
программ STATISTICA / О. Ю. Реброва. – М.: МедиаСфера, 2002. – 312 с.
7. Руководство по экспериментальному (доклиническому) излучению
новых фармакологических веществ / Под общей редакцией чл.-корр. РАМН проф. Р.
У. Хабриева. – 2-изд., перераб. и доп. – М.: Медицина, 2005. – 832 с.
8. Сернов Л. Н. Элементы экспериментальной фармакологии / Л. Н.
Сернов, В. В. Гацура. – М.: ВНЦ БАВ,
2000. – 352 с.